NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
14.68
+0.54 (3.78%)
Nov 5, 2024, 1:17 PM EST - Market open
NeoGenomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 644.12 | 591.64 | 509.73 | 484.33 | 444.45 | 408.83 | Upgrade
|
| Revenue Growth (YoY) | 12.06% | 16.07% | 5.24% | 8.97% | 8.71% | 47.73% | Upgrade
|
| Cost of Revenue | 363.69 | 347.04 | 321.83 | 297.27 | 258.56 | 211.99 | Upgrade
|
| Gross Profit | 280.43 | 244.6 | 187.9 | 187.06 | 185.89 | 196.84 | Upgrade
|
| Selling, General & Admin | 335.34 | 313.04 | 310.68 | 283.94 | 191.66 | 175.34 | Upgrade
|
| Research & Development | 30.32 | 27.31 | 30.33 | 21.87 | 8.23 | 8.49 | Upgrade
|
| Operating Expenses | 365.65 | 340.35 | 341 | 305.81 | 199.89 | 183.83 | Upgrade
|
| Operating Income | -85.22 | -95.75 | -153.11 | -118.75 | -13.99 | 13.01 | Upgrade
|
| Interest Expense | -6.67 | -6.91 | -7.58 | -8.22 | -7.02 | -3.71 | Upgrade
|
| Interest & Investment Income | 18.94 | 16.9 | 6.08 | 112.4 | 3.96 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.18 | 0.64 | -0.21 | -0.5 | 0.01 | -4.63 | Upgrade
|
| EBT Excluding Unusual Items | -72.78 | -85.11 | -154.83 | -15.08 | -17.05 | 4.66 | Upgrade
|
| Merger & Restructuring Charges | -6.16 | -11.09 | -4.52 | - | - | - | Upgrade
|
| Other Unusual Items | -0.9 | -0.9 | - | - | 2.99 | -1.02 | Upgrade
|
| Pretax Income | -79.83 | -97.1 | -159.34 | -15.08 | -14.06 | 3.65 | Upgrade
|
| Income Tax Expense | -2.11 | -9.13 | -15.09 | -6.73 | -18.23 | -4.36 | Upgrade
|
| Net Income | -77.73 | -87.97 | -144.25 | -8.35 | 4.17 | 8.01 | Upgrade
|
| Net Income to Common | -77.73 | -87.97 | -144.25 | -8.35 | 4.17 | 8.01 | Upgrade
|
| Net Income Growth | - | - | - | - | -47.89% | 203.26% | Upgrade
|
| Shares Outstanding (Basic) | 126 | 126 | 124 | 120 | 109 | 100 | Upgrade
|
| Shares Outstanding (Diluted) | 126 | 126 | 124 | 120 | 112 | 104 | Upgrade
|
| Shares Change (YoY) | 0.93% | 1.03% | 3.55% | 7.31% | 7.89% | 13.16% | Upgrade
|
| EPS (Basic) | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 | Upgrade
|
| EPS (Diluted) | -0.62 | -0.70 | -1.16 | -0.07 | 0.04 | 0.08 | Upgrade
|
| EPS Growth | - | - | - | - | -51.78% | 13.84% | Upgrade
|
| Free Cash Flow | -21.51 | -30.71 | -96.88 | -90.87 | -27.64 | 3.34 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | -0.24 | -0.78 | -0.76 | -0.25 | 0.03 | Upgrade
|
| Gross Margin | 43.54% | 41.34% | 36.86% | 38.62% | 41.83% | 48.15% | Upgrade
|
| Operating Margin | -13.23% | -16.18% | -30.04% | -24.52% | -3.15% | 3.18% | Upgrade
|
| Profit Margin | -12.07% | -14.87% | -28.30% | -1.72% | 0.94% | 1.96% | Upgrade
|
| Free Cash Flow Margin | -3.34% | -5.19% | -19.01% | -18.76% | -6.22% | 0.82% | Upgrade
|
| EBITDA | -12.5 | -23.17 | -83.68 | -65.4 | 21.73 | 43.28 | Upgrade
|
| EBITDA Margin | -1.94% | -3.92% | -16.42% | -13.50% | 4.89% | 10.59% | Upgrade
|
| D&A For EBITDA | 72.72 | 72.58 | 69.43 | 53.35 | 35.72 | 30.27 | Upgrade
|
| EBIT | -85.22 | -95.75 | -153.11 | -118.75 | -13.99 | 13.01 | Upgrade
|
| EBIT Margin | -13.23% | -16.18% | -30.04% | -24.52% | -3.15% | 3.18% | Upgrade
|
| Revenue as Reported | 644.12 | 591.64 | 509.73 | 484.33 | 444.45 | 408.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.